Isbister GK. Risk assessment of drug-induced QT prolongation. Aust Prescr. 2015;38(1):20–4.

Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010 Mar;121(8):1047–60.

Li M, Ramos LG. Drug-induced QT prolongation and torsades de pointes. P T. 2017;42(7):473–7.

Othong R, Wattanasansomboon S, Kruutsaha T, Chesson D, Vallibhakara SA, Kazzi Z. Utility of QT interval corrected by Rautaharju method to predict drug-induced torsade de pointes. Clin Toxicol. 2019;57(4):234–9.

Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003 Nov;89(11):1363–72.

Isbister GK, Page CB. Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol. 2013 Jul;76(1):48–57.

Kan AA, de Lange DW, Donker DW, Meulenbelt J. Management of prolonged QT interval and torsades de pointes in the intoxicated patient. Neth J Med. 2014 Apr;72(3):119–26.

Lund K, Perkiömäki JS, Brohet C, Elming H, Zaïdi M, Torp-Pedersen C, et al. The prognostic accuracy of different QT interval measures. Ann Noninvasive Electrocardiol. 2002;7(1):10–6.

Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation. 1952;6(3):378–88.

Lanjewar P, Pathak V, Lokhandwala Y. Issues in QT interval measurement. Indian Pacing Electrophysiol J. 2004;4(4):156–61.

Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias C. J Am Coll Cardiol. 2009 Mar;53(11):982–91.

Postema PG, Wilde AAM. The measurement of the QT interval. Curr Cardiol Rev. 2014;10(3):287–94.

Sharma S, Drezner JA, Baggish A, Papadakis M, Wilson MG, Prutkin JM, et al. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J. 2018;39(16):1466–80.

Woosley R, Heise C, Romero K. QT drug lists [Internet]. CredibleMeds®. 2021 [cited 2019 Mar 29]. Available from: www.Crediblemeds.org

Newman TB, Browner WS, Cummings SR, Hulley SB. Designing studies of medical tests. In: Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB, editors. Designing clinical research. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 171–91.

Rutjes AWS, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PMM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005 Aug;51(8):1335–41.

Pepe MS, Fan J, Seymour CW, Li C, Huang Y, Feng Z. Biases introduced by choosing controls to match risk factors of cases in biomarker research. Clin Chem. 2012 Aug;58(8):1242–51.

Pencina MJ. Caution is needed in the interpretation of added value of biomarkers analyzed in matched case control studies. Clin Chem. 2012 Aug;58(8):1176–8.

Othong R, Devlin JJ, Kazzi ZN. Medical toxicologists’ practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region. Clin Toxicol. 2015;53(4):204–9.

Vandenberk B, Vandael E, Robyns T, Vandenberghe J, Garweg C, Foulon V, et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc. 2016;5(6):e003264.

Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014;48:193–204.

Kasamaki Y, Ozawa Y, Ohta M, Sezai A, Yamaki T, Kaneko M, et al. Automated versus manual measurement of the QT interval and corrected QT interval. Ann Noninvasive Electrocardiol. 2011;16(2):156–64.